Categories: Business

Cognizant Unveils Next-Gen Cyber Defense Center in Bengaluru

To deliver advanced AI-powered cybersecurity defense operations for global enterprises

- Advertisement -

BENGALURU, India, Dec. 15, 2025 /PRNewswire/ — Cognizant (NASDAQ: CTSH) today announced the launch of its Next-Gen Cyber Defense Center (CDC) in Bengaluru. This center is key to the company’s worldwide CDC network and is Cognizant’s largest facility designed to deliver advanced AI powered platform centric cybersecurity managed services, engineering and transformation services to clients globally.

- Advertisement -

Cognizant has a strong cybersecurity practice with longstanding experience, driven by seasoned professionals with deep expertise. At the Bengaluru CDC, these specialists aim to provide round-the-clock monitoring and rapid response to security incidents, supporting clients across diverse industries and geographies. The center features an integrated threat research lab, supported by strategic alliances with leading technology companies.

- Advertisement -

“Cybersecurity is entering a new era where hyper-connected enterprises and AI-driven threats outpace traditional defenses,” said Ravi Kumar S, CEO, Cognizant. “Our new Cyber Defense Center in Bengaluru reflects our commitment to delivering intelligence-led cybersecurity engineering and operation services that help enable clients to predict, prevent and mitigate advanced cybersecurity threats.”

- Advertisement -

The Bengaluru CDC is built on a multi-layered technology architecture that combines Cognizant’s proprietary innovations, such as Cognizant Neuro® Cybersecurity, with industry-leading platforms from technology partners to deliver advanced cybersecurity capabilities. To support a steady pipeline of skilled talent, the center has partnered with leading academic institutions to train next-generation cybersecurity professionals.

- Advertisement -

Through its global network of Cyber Defense Centers, Cognizant is expanding its capabilities aiming to deliver comprehensive enterprise cybersecurity services, assisting clients build risk resilience while advancing innovation in cyber defense strategies.

- Advertisement -

About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we’re improving everyday life. See how at www.cognizant.com or @cognizant.

- Advertisement -

For more information, contact:

- Advertisement -

Name: Sharon Lobo
Email: sharon.lobo@cognizant.com

- Advertisement -

Photo – https://mma.prnewswire.com/media/2845642/Cognizant_CDC_Bengaluru_inaguration.jpg
Logo – https://mma.prnewswire.com/media/1794711/Cognizant_Logo_V1.jpg

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/cognizant-unveils-next-gen-cyber-defense-center-in-bengaluru-302642447.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

2 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

1 week ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

4 weeks ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago